Machine Learning-Enhanced Engineering of Ultrahigh-Loading Polymer-Drug Assemblies with Programmable ROS-Triggered Release for Tumor Elimination

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-06 · read from full text

This preprint reports the rational design of polysulfide nanocarriers engineered with optimized non-covalent polymer–drug interactions to achieve ultrahigh loading capacities (up to ~50 wt.%) across diverse small-molecule therapeutics, using machine learning and Bayesian feature refinement to predict loading capacity from only four critical features. The authors then tune polysulfide composition to produce ROS-responsive copolymers that maintain stable encapsulation and trigger oxidation-triggered drug release under cancer-relevant conditions, with ultrahigh-loaded paclitaxel-polysulfide particles showing improved pharmacology and antitumor performance versus clinical Taxol. A slow-release formulation outperformed a fast-release formulation in an orthotopic triple negative breast cancer model, achieving complete tumor eradication in 3 of 8 animals. The study is presented as a preprint and therefore has not been peer reviewed, and the reported performance is demonstrated in specific experimental models rather than broader validation. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 17,213 characters · extracted from preprint-html · click to expand
Machine Learning-Enhanced Engineering of Ultrahigh-Loading Polymer-Drug Assemblies with Programmable ROS-Triggered Release for Tumor Elimination | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Machine Learning-Enhanced Engineering of Ultrahigh-Loading Polymer-Drug Assemblies with Programmable ROS-Triggered Release for Tumor Elimination Craig Duvall, Richard d'Arcy, Sarah Hall, Steve Wilson, Mariah Bezold, and 15 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8507915/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Overcoming low solubility and bioavailability challenges is critical for enhancing therapeutic efficacy and reducing systemic toxicity of active pharmaceutical ingredients. Here, we describe the rational design of polysulfide nanocarriers that leverage optimized non-covalent polymer-drug interactions—specifically hydrogen bonding, π-interactions, and ion-pairing—to achieve ultrahigh loading capacities (up to ~50 wt.%) across diverse small-molecule therapeutics. Employing machine learning and Bayesian-driven feature refinement, only 4 critical features accurately predicted loading capacity with a mean absolute error of only 2.23% for physically loaded drugs. By systematically tuning polysulfide composition, we created ROS-responsive copolymers capable of stable drug encapsulation and controlled, oxidation-triggered release, tailored for cancer environments. As proof-of-concept, ultrahigh-loaded paclitaxel-polysulfide particles were formulated, showing significantly increased maximum tolerated doses, plasma circulation, tumor retention, and antitumor efficacy compared to clinical standard Taxol. Notably, a Slow-release formulation outperformed a Fast-release formulation, achieving complete tumor eradication in 3-out-of-8 animals in an orthotopic triple negative breast cancer model, emphasizing the importance of curated drug-polymer interactions in nanomedicine. This approach provides critical insights for advancing next-generation delivery platforms and broadening clinical translation possibilities. Physical sciences/Nanoscience and technology/Nanomedicine/Drug delivery Physical sciences/Materials science/Nanoscale materials/Nanoparticles Physical sciences/Chemistry/Polymer chemistry/Polymer synthesis Biological sciences/Biotechnology/Biomaterials/Drug delivery Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryDataSet.xlsx Supplementary Data Set SupportingInformation.docx Supplementary Information Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8507915","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":584425017,"identity":"e0cc19b7-3412-4eca-95fd-b33882e80d99","order_by":0,"name":"Craig Duvall","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0003-3979-0620","institution":"Vanderbilt University","correspondingAuthor":true,"prefix":"","firstName":"Craig","middleName":"","lastName":"Duvall","suffix":""},{"id":584425018,"identity":"e55fc715-25fe-46f0-80be-b35afc81fb3e","order_by":1,"name":"Richard d'Arcy","email":"","orcid":"","institution":"Arizona State University","correspondingAuthor":false,"prefix":"","firstName":"Richard","middleName":"","lastName":"d'Arcy","suffix":""},{"id":584425019,"identity":"f95d6c3b-f52d-4021-abf5-79e249dbb63b","order_by":2,"name":"Sarah Hall","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Sarah","middleName":"","lastName":"Hall","suffix":""},{"id":584425020,"identity":"ef5cd121-9154-4c9a-83bb-08de85aaeb16","order_by":3,"name":"Steve Wilson","email":"","orcid":"","institution":"PsaiForge","correspondingAuthor":false,"prefix":"","firstName":"Steve","middleName":"","lastName":"Wilson","suffix":""},{"id":584425021,"identity":"eb4564f7-c23b-4923-972d-0443fde0c3df","order_by":4,"name":"Mariah Bezold","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Mariah","middleName":"","lastName":"Bezold","suffix":""},{"id":584425022,"identity":"637ab77f-6409-46e5-9b7d-bad322364a42","order_by":5,"name":"Patrick Gerber","email":"","orcid":"https://orcid.org/0009-0005-4150-7590","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Patrick","middleName":"","lastName":"Gerber","suffix":""},{"id":584425023,"identity":"39e08640-b654-4152-9bde-cdb192f274c6","order_by":6,"name":"Marcus Bernard","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Marcus","middleName":"","lastName":"Bernard","suffix":""},{"id":584425024,"identity":"ff95992b-cad6-4761-9b78-304bb16770b7","order_by":7,"name":"Jean Jerome","email":"","orcid":"","institution":"Brown University","correspondingAuthor":false,"prefix":"","firstName":"Jean","middleName":"","lastName":"Jerome","suffix":""},{"id":584425025,"identity":"70515a0e-2ab6-40bd-8db2-e65cf9daffc8","order_by":8,"name":"Norar Francini","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Norar","middleName":"","lastName":"Francini","suffix":""},{"id":584425026,"identity":"0effea30-fb0b-463d-aa76-00ded0a59495","order_by":9,"name":"Natalie Bennett","email":"","orcid":"","institution":"Vanderbilt University Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Natalie","middleName":"","lastName":"Bennett","suffix":""},{"id":584425027,"identity":"66c00f42-0e26-46b6-a051-fa822bf843bd","order_by":10,"name":"Patricia Poley","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Patricia","middleName":"","lastName":"Poley","suffix":""},{"id":584425028,"identity":"175928a3-4fb9-45d5-a2e6-999ce338f144","order_by":11,"name":"Amelia Soltes","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Amelia","middleName":"","lastName":"Soltes","suffix":""},{"id":584425029,"identity":"5f03bf0c-fb96-40d9-a2a2-f6433c8118ab","order_by":12,"name":"Fang Yu","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Fang","middleName":"","lastName":"Yu","suffix":""},{"id":584425030,"identity":"ff9aac9f-74df-4fd6-a500-d094be413bb0","order_by":13,"name":"Carlisle DeJulius","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Carlisle","middleName":"","lastName":"DeJulius","suffix":""},{"id":584425031,"identity":"2b3c806e-5f8e-4593-be28-bf1fa7479c8b","order_by":14,"name":"Shrusti Patel","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Shrusti","middleName":"","lastName":"Patel","suffix":""},{"id":584425032,"identity":"f8ea72df-ded7-407c-9cad-6be1eaacf7fc","order_by":15,"name":"Kristopher Castillo","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Kristopher","middleName":"","lastName":"Castillo","suffix":""},{"id":584425033,"identity":"9470c43e-cb3a-47ce-b7a6-c619f75de2d8","order_by":16,"name":"Justin Lo","email":"","orcid":"","institution":"Vanderbilt University Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Justin","middleName":"","lastName":"Lo","suffix":""},{"id":584425034,"identity":"1d869466-1f3e-4fd6-8b2a-cd55cb92df19","order_by":17,"name":"Julie Rhoades","email":"","orcid":"","institution":"Vanderbilt University Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Julie","middleName":"","lastName":"Rhoades","suffix":""},{"id":584425035,"identity":"ecbad044-2d0f-4f3d-8eb1-7ff8dee1d7b6","order_by":18,"name":"Rebecca Cook","email":"","orcid":"","institution":"Vanderbilt University","correspondingAuthor":false,"prefix":"","firstName":"Rebecca","middleName":"","lastName":"Cook","suffix":""},{"id":584425036,"identity":"fbb6e850-f44e-4ac4-9f23-08cec7656269","order_by":19,"name":"Christopher Muhich","email":"","orcid":"https://orcid.org/0000-0003-3089-559X","institution":"Arizona State University","correspondingAuthor":false,"prefix":"","firstName":"Christopher","middleName":"","lastName":"Muhich","suffix":""}],"badges":[],"createdAt":"2026-01-03 15:40:15","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8507915/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8507915/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":105565571,"identity":"d9f5b185-b830-4b8a-a41b-d466d177e347","added_by":"auto","created_at":"2026-03-27 12:53:38","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3307237,"visible":true,"origin":"","legend":"","description":"","filename":"ManuscriptFinal.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8507915/v1_covered_d9bf0d49-3147-4056-9910-7dbfdd1bd7dc.pdf"},{"id":101743377,"identity":"2fd314ea-26ca-4312-a947-2d6ec31513c2","added_by":"auto","created_at":"2026-02-03 08:46:48","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":86741,"visible":true,"origin":"","legend":"Supplementary Data Set","description":"","filename":"SupplementaryDataSet.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-8507915/v1/f61191b6dee72656ec9d0ac7.xlsx"},{"id":101743378,"identity":"8ad0a8e9-d1f7-41b1-a1ed-a0e72d465cb7","added_by":"auto","created_at":"2026-02-03 08:46:48","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":7432142,"visible":true,"origin":"","legend":"Supplementary Information","description":"","filename":"SupportingInformation.docx","url":"https://assets-eu.researchsquare.com/files/rs-8507915/v1/a7fb621a500159ab9c5c6830.docx"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Machine Learning-Enhanced Engineering of Ultrahigh-Loading Polymer-Drug Assemblies with Programmable ROS-Triggered Release for Tumor Elimination","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-8507915/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8507915/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Overcoming low solubility and bioavailability challenges is critical for enhancing therapeutic efficacy and reducing systemic toxicity of active pharmaceutical ingredients. Here, we describe the rational design of polysulfide nanocarriers that leverage optimized non-covalent polymer-drug interactions—specifically hydrogen bonding, π-interactions, and ion-pairing—to achieve ultrahigh loading capacities (up to ~50 wt.%) across diverse small-molecule therapeutics. Employing machine learning and Bayesian-driven feature refinement, only 4 critical features accurately predicted loading capacity with a mean absolute error of only 2.23% for physically loaded drugs. By systematically tuning polysulfide composition, we created ROS-responsive copolymers capable of stable drug encapsulation and controlled, oxidation-triggered release, tailored for cancer environments. As proof-of-concept, ultrahigh-loaded paclitaxel-polysulfide particles were formulated, showing significantly increased maximum tolerated doses, plasma circulation, tumor retention, and antitumor efficacy compared to clinical standard Taxol. Notably, a Slow-release formulation outperformed a Fast-release formulation, achieving complete tumor eradication in 3-out-of-8 animals in an orthotopic triple negative breast cancer model, emphasizing the importance of curated drug-polymer interactions in nanomedicine. This approach provides critical insights for advancing next-generation delivery platforms and broadening clinical translation possibilities.","manuscriptTitle":"Machine Learning-Enhanced Engineering of Ultrahigh-Loading Polymer-Drug Assemblies with Programmable ROS-Triggered Release for Tumor Elimination","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-02-03 08:46:36","doi":"10.21203/rs.3.rs-8507915/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"10520dd7-97ea-41b4-b678-3db9b4e4dd94","owner":[],"postedDate":"February 3rd, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":62170862,"name":"Physical sciences/Nanoscience and technology/Nanomedicine/Drug delivery"},{"id":62170863,"name":"Physical sciences/Materials science/Nanoscale materials/Nanoparticles"},{"id":62170864,"name":"Physical sciences/Chemistry/Polymer chemistry/Polymer synthesis"},{"id":62170865,"name":"Biological sciences/Biotechnology/Biomaterials/Drug delivery"}],"tags":[],"updatedAt":"2026-03-25T12:58:39+00:00","versionOfRecord":[],"versionCreatedAt":"2026-02-03 08:46:36","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8507915","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8507915","identity":"rs-8507915","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-4.0